U.S. Pharma Stock News

Whether you are wondering if Post Holdings at around US$95.70 offers good value or if the market is pricing in too much optimism, this breakdown is designed to help you frame that question clearly. The share price has slipped 1.1% over the last week, 8.4% over the last month, and 16.9% over the last year, which may change how you think about both risk and opportunity here. Recent coverage has focused on Post Holdings as a packaged food company in a sector where investors often weigh...

If you are wondering whether Sotera Health's current share price still offers value, you are not alone. Many investors are asking the same question. The stock last closed at US$13.13, with returns of a 2.7% decline over 7 days, an 18.8% decline over 30 days, a 25.8% decline year to date, an 11.6% gain over 1 year, a 26.7% decline over 3 years, and a 47.5% decline over 5 years. Recent coverage has focused on Sotera Health as a recurring name in ongoing discussions about healthcare and life...

In March 2026, Gevo, Inc. announced that board member Angelo Amorelli will not stand for re-election at the upcoming annual meeting, while company leaders present at the H.C. Wainwright Renewable Fuels Virtual Day and the 38th Annual Roth Conference to highlight its renewable fuels initiatives. Together, the board transition and conference appearances may influence how investors assess Gevo’s governance, visibility with institutional audiences, and long-term positioning in low-carbon...

Conference spotlight and recent stock performance Honest Company (HNST) is set to present at the 38th Annual Roth Conference on March 23, 2026, an investor focused event that has drawn fresh attention to the stock. With investor relations lead Chris Mandeville and CFO Curtiss Bruce scheduled to speak, the conference appearance comes after a recent one month gain of about 25% and a past three month return near 6%. See our latest analysis for Honest Company. The current share price of US$2.88...

Pony AI Inc. reported past fourth-quarter 2025 revenue of US$29.13 million versus US$35.52 million a year earlier, but moved from a net loss of US$180.91 million to net income of US$23.43 million, while also expanding its robotaxi footprint through new partnerships and Gen-7 Robotaxi deployments. Uber, Verne, and Pony AI recently announced a partnership to launch what they describe as Europe’s first commercial robotaxi service in Zagreb, highlighting how Pony AI’s technology-licensing and...

In March 2026, Satellogic Inc. announced Merlin, a new constellation aimed at enabling daily one-meter global remapping, and disclosed an expanded Slingshot maritime intelligence program with Innovative Defense Technologies and the U.S. Office of Naval Research that will grow its ISL-equipped fleet to eight satellites by 2027. Away from product and defense developments, Satellogic also reported full-year 2025 sales of US$17.71 million with a sharply reduced net loss of US$4.78 million, and...

If you are wondering whether Forgent Power Solutions at around US$30.64 is a bargain or just fairly priced, the recent share moves give you a starting point but not the full story. The stock has seen an 8.4% decline over the last week and a 10.8% decline over the last month, even though the year to date return sits at 5.7%. Recent coverage has focused on Forgent Power Solutions within the Electrical industry and how investors are reassessing company specific fundamentals in that context...

Event context and recent price performance With no specific news event flagged, Geron (GERN) has still been on investors’ radar after a 9.1% one day decline. This adds to a one month return of an 18.6% decline and a modest gain over the past 3 months. See our latest analysis for Geron. At a share price of $1.40, Geron’s recent 9.1% one day and 18.6% 30 day share price declines sit against a 6.1% year to date share price gain and a 15.2% one year total shareholder return decline. This suggests...

Why MasterBrand Stock Is Back on Investors’ Radar MasterBrand (MBC) has drawn attention after a period of weaker share performance, with the stock showing negative total returns over the past year and the past 3 months despite positive 3 year performance. See our latest analysis for MasterBrand. The recent 7 day share price return of 7.67% stands in contrast to a 30 day share price decline of 21.74% and a year to date share price return of negative 26.60%. At the same time, the 3 year total...

Argan (AGX) closed out FY 2026 with fourth quarter revenue of US$262.1 million and basic EPS of US$3.54, capping a year in which trailing twelve month revenue reached US$944.6 million and EPS came in at US$10.00. Over recent periods the company has seen quarterly revenue shift between US$193.7 million and US$262.1 million, with basic EPS ranging from US$1.65 to US$3.54 as earnings growth of 61.2% over the past year and a higher net profit margin of 14.6% set the tone for this latest update...

ACI Worldwide (NasdaqGS:ACIW) released its latest Tax Payment Trends report, highlighting a generational shift in tax filing and payment behaviors. The research points to a substantial portion of Gen Z not engaging in federal tax filing and underscores a widening digital divide in how consumers handle taxes. The report provides new insight into consumer expectations around digital payments and financial interactions, with potential implications for tax authorities and payment providers. ACI...

Marriott International (NasdaqGS:MAR) receives 2026 Platinum Employer recognition on the Where You Work Matters List, reportedly as the only hotel company on the list. The company confirms the reopening and renovation of the ARC Hotel in Washington DC as part of the Series by Marriott brand. The developments highlight Marriott's focus on workplace opportunity and its Series by Marriott offering for experience driven and urban travelers. For investors following NasdaqGS:MAR, these updates...

Navan (NAVN) is back in focus after its latest earnings report, where strong Q4 and full year revenue, earlier than planned free cash flow positivity, and AI driven products like Navan Edge caught investor attention. See our latest analysis for Navan. The latest earnings release and upbeat guidance have pulled fresh attention to Navan, even as the share price has been volatile. A 7 day share price return of 37.7% and a year to date share price return decline of 24.9% suggest that short term...

Belden (NYSE:BDC) has been named to Newsweek’s America’s Most Responsible Companies list for a third consecutive year. The company reports achieving key sustainability milestones, including surpassing certain greenhouse gas reduction targets. Belden has expanded its Great Place to Work certification across more global locations. The company plans to introduce new long-term environmental, social, and governance goals in Spring 2026. Belden, listed on the NYSE under the ticker BDC, supplies...

Wondering if National Fuel Gas at around US$95.29 is still reasonably priced after a strong run, or if you might be turning up late to the story. The stock has returned 3.9% over the past week, 7.7% over the last month, 16.1% year to date, and 24.0% over the past year. This naturally raises questions about how much value is already reflected in the price. Recent coverage has focused on National Fuel Gas as a vertically integrated gas utility and energy company, with attention on how it...

Wondering whether Cleveland-Cliffs at a last close of US$8.11 offers value or a value trap? This breakdown will help you frame the price against what the business may be worth. The stock has recently shown mixed performance, with a 3.7% gain over the last 7 days but declines of 24.8% over 30 days, 40.4% year to date, and 4.8% over the past year. These moves sit against a longer track record that shows 55.8% and 58.2% declines over the past 3 and 5 years respectively. This can influence how...

Summit Therapeutics presented new Phase III data on ivonescimab at the 2026 European Lung Cancer Congress in EGFR mutated NSCLC. The data highlighted improved intracranial progression free survival, including in patients with brain metastases. The company has submitted a Biologics License Application to the FDA, with a PDUFA decision date set for November. Summit Therapeutics, trading as NasdaqGM:SMMT, is drawing attention after sharing these late stage results alongside a confirmed FDA...

Oklahoma Gas and Electric Company, a subsidiary of OGE Energy (NYSE:OGE), announced a new fixed-income offering of callable senior and subordinated unsecured fixed rate notes. The notes are structured as unsecured obligations and include both senior and subordinated tranches, with fixed interest rates. The securities are callable, meaning the issuer may choose to redeem them before maturity, subject to the offering terms. OGE Energy, through Oklahoma Gas and Electric, operates as a...

Some investors may be considering whether Grindr's current share price reflects its potential value, or whether the market is mispricing the stock at present. Over the past month, Grindr's share price has moved by 11.3%, while the 1 year return shows a 29.8% decline. This may draw the attention of investors who are weighing recent momentum against longer term performance. Recent coverage around Grindr has focused on its position as a listed interactive media and services platform, including...

H.B. Fuller (NYSE:FUL) secured key raw materials after more than 40 force majeure notices linked to Middle East related supply disruptions. The company plans a minimum 10% global price increase effective April 1, 2026, to address inflation and raw material cost pressures. Management has paused acquisitions to focus on debt reduction and share buybacks, which signals a shift in capital allocation priorities. For investors watching NYSE:FUL, the share price sits at $59.17, with a 20.0% gain...

Revvity (NYSE:RVTY) plans to hold its annual meeting on April 28, 2026. Shareholders will vote on a proposed bylaw change to let holders of 25% of shares call special meetings. Activist-backed proposals seek tighter executive stock retention requirements tied to equity compensation. Revvity, which operates in life sciences and diagnostics, sits in a sector where governance practices are closely watched, partly because R&D cycles and regulatory oversight can shape capital allocation...

Earlier this week, Gates Industrial Corporation, a manufacturer of engineered power transmission and fluid power solutions, was lifted by easing geopolitical tensions as postponed military action against Iran reduced perceived risk for globally exposed industrial companies. This shift in geopolitical risk sentiment matters for Gates because its end markets, including construction equipment and manufacturing, are closely tied to global economic stability and confidence in longer-term capital...

If you are wondering whether Ligand Pharmaceuticals at around US$195 a share still offers value, the next sections will walk through what the current price might be implying about the business. The stock has delivered an 81.6% return over 1 year and 165.7% over 3 years, while the shorter term picture shows a 4.6% decline over 7 days alongside modest gains of 2.1% over 30 days and 2.8% year to date. Recent coverage of Ligand Pharmaceuticals has focused on its role in the wider pharmaceuticals...

Sportradar Group (NasdaqGS:SRAD) has introduced Playradar, a new iGaming brand that combines live sports streaming with casino style gaming experiences. The company has also expanded its relationship with Hard Rock Bet to include official PGA TOUR and UFC data plus more advanced in play betting features. These updates extend Sportradar's role beyond core sports data into hybrid gaming products while deepening ties with a major US betting operator. Sportradar Group, trading at $17.15, is...